TCG Crossover Management’s Obsidian Therapeutics OBX Stock Holding History
Bought
Maintained
Sold
Other funds holding OBX
TCG Crossover Management's OBX Position: Q3 2026 in Review
TCG Crossover Management opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 2,196,138 shares worth $30.2M. The stake represents 0.85% of the portfolio and ranks #31 among its holdings.
60 funds tracked by Wall St. Rank hold OBX as of Q3 2026.
- TCG Crossover Management held 2,196,138 shares of Obsidian Therapeutics worth $30.2M as of Q3 2026.
- Obsidian Therapeutics was a new TCG Crossover Management position in Q3 2026.
- Obsidian Therapeutics made up 0.85% of TCG Crossover Management's portfolio in Q3 2026, its #31 holding.
- 60 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.
Based on TCG Crossover Management's 13F filing for Q3 2026, filed 16 Nov 2026.